Surgical Treatment for Type A Aortic Dissection after Endovascular Aortic Repair: A 12-year, Single-Center Study

Yuan Xue,Shipan Wang,Xuehuan Zhang,Xiaomeng Wang,Yue Shi,Hongjia Zhang,Duanduan Chen,Haiyang Li
DOI: https://doi.org/10.1007/s10557-024-07565-1
2024-03-16
Cardiovascular Drugs and Therapy
Abstract:This study aims to investigate the clinical manifestations, operative techniques, and outcomes of patients who undergo open repair after thoracic endovascular aortic repair (TEVAR).
pharmacology & pharmacy,cardiac & cardiovascular systems
What problem does this paper attempt to address?
This paper aims to explore the clinical manifestations, surgical techniques and results of open - surgery treatment for type A aortic dissection (TAAD) after thoracic endovascular aortic repair (TEVAR). Specifically, the study focused on two different types of TAAD: retrograde type A dissection (RTAD) and proximal new - onset aortic dissection (PNAD). By reviewing the data of 113 TAAD patients who underwent secondary open - surgery in a single center over the past 12 years, the study analyzed the clinical characteristics, surgical methods and prognosis of these patients. ### Main research questions: 1. **Clinical manifestations**: The study described the clinical characteristics of patients with TAAD after TEVAR, including age, gender, comorbidities, reasons for admission, etc. 2. **Surgical techniques**: The types of surgery received by patients, such as total arch replacement (TAR) plus frozen elephant trunk technique (FET), hemi - arch replacement (HAR), etc., were recorded in detail, and key data during the surgical process, such as cardiopulmonary bypass time, aortic cross - clamping time, etc., were analyzed. 3. **Prognosis results**: The postoperative survival rate, length of hospital stay, length of ICU stay, mechanical ventilation time and postoperative complications of patients were evaluated. ### Research background: - **Widespread use of TEVAR**: TEVAR has become the preferred method for treating thoracic aortic aneurysms and dissections, especially in high - risk patients. - **Complications after TEVAR**: Although TEVAR has the advantage of minimally invasive, its complications cannot be ignored, especially the occurrence of TAAD, which is rare but has a high mortality rate. - **Classification of TAAD**: According to anatomical characteristics, TAAD can be divided into two types: RTAD and PNAD. RTAD is usually related to stent - graft - related factors, while PNAD is manifested as a new intimal tear, and the tear does not contact the stent - graft. ### Research methods: - **Patient selection**: From January 2010 to June 2022, a total of 113 TAAD patients who underwent secondary open - surgery after TEVAR were included. - **Grouping**: Patients were divided into RTAD group (56 cases) and PNAD group (57 cases) according to anatomical characteristics. - **Data analysis**: Kaplan - Meier survival curves and log - rank tests were used for survival analysis to compare the survival rates and other clinical indicators of the two groups of patients. ### Main findings: - **Good early and intermediate prognosis**: The 30 - day mortality rate was 6.2%, and the overall survival rates at 1 year, 5 years and 10 years were 88.5%, 88.5% and 87.6% respectively. - **Characteristics of the PNAD group**: Compared with the RTAD group, the ascending aortic diameter in the PNAD group was larger (48.4 ± 11.4 mm vs 42.5 ± 7.7 mm), and the proximal landing zone was closer. - **Surgical techniques**: Most patients underwent TAR + FET surgery, and a small number of patients underwent HAR or isolated ascending aortic replacement. ### Conclusions: - **Management of TAAD after TEVAR**: Although the incidence of TAAD after TEVAR is low, once it occurs, open - surgery treatment needs to be carried out in a timely manner. The study results show that this treatment method has a good prognosis in the early and intermediate stages. - **Importance of regular follow - up**: Patients after TEVAR should be followed up for a long time to detect TAAD early and intervene in a timely manner. ### Discussion: - **Potential risks of TEVAR**: The occurrence of TAAD after TEVAR may be related to multiple factors, including the selection of stent - grafts, the fragility of the aortic wall, hypertension, etc. - **Preventive measures**: The study recommends selecting appropriate stent - grafts, avoiding choosing the affected aortic wall as the proximal landing zone in the acute phase, and controlling postoperative blood pressure, etc., to reduce the occurrence of TAAD. ### Limitations: - **Retrospective study**: The retrospective design of the study and the small sample size limit the accurate estimation of the incidence of TAAD. - **Selection bias**: Many patients were referred from other hospitals, so it was impossible to fully understand the details of their previous TEVAR, which may affect the analysis of the risk factors for recurrent dissection. In conclusion, this study provides important clinical evidence for the management and prevention of TAAD after TEVAR, emphasizing the importance of regular follow - up and early diagnosis.